Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 39 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Terpos, Evangelos [Clear All Filters]
Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis..
J Clin Exp Hepatol. 14(3), 101353.
(2024). Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implications..
Hepatobiliary Pancreat Dis Int.
(2023). Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass..
J Musculoskelet Neuronal Interact. 19(3), 253-257.
(2019). The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents..
Blood. 131(4), 464-467.
(2018). Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases..
Leuk Lymphoma. 59(4), 983-987.
(2018).
(2018). Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis..
Blood Cancer J. 8(5), 46.
(2018). Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis..
Blood. 131(14), 1568-1575.
(2018). Mild leukopenia following denosumab treatment in a woman with postmenopausal osteoporosis..
Endocrine. 62(2), 487-489.
(2018). Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment..
Hormones (Athens). 17(4), 573-579.
(2018).
(2018).
(2018). Cardiac and renal complications of carfilzomib in patients with multiple myeloma..
Blood Adv. 1(7), 449-454.
(2017). Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma..
Haematologica. 102(3), 593-599.
(2017). Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens..
Leuk Lymphoma. 58(8), 1832-1839.
(2017). Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity..
Metabolism. 71, 198-201.
(2017). Periostin and sclerostin levels in juvenile Paget's disease..
Clin Cases Miner Bone Metab. 14(2), 269-271.
(2017). Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia..
Leuk Lymphoma. 58(6), 1506-1508.
(2017). Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy..
Am J Hematol. 92(7), 632-639.
(2017). Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis..
Am J Hematol. 91(5), 499-502.
(2016). Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease..
J Bone Miner Metab. 34(4), 447-56.
(2016). Clinical vertebral fractures following denosumab discontinuation..
Endocrine. 54(1), 271-272.
(2016). Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment..
Expert Opin Ther Targets. 19(3), 299-306.
(2015).
(2015).
(2015).